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Abstract
We have developed a new double in vivo biotinylation (DIB) technique that may be used 
for assessing turnover patterns of erythrocytes in circulation. This technique involves two 
successive in vivo biotinylation steps, interspersed by a period of 5–30 days, which would 
enable us to tag with biotin a population of erythrocytes entering blood circulation over 
a defined period of time, between the two biotinylation steps. As such we can track the 
age-related changes in a lifetime of the circulating erythrocytes, or we can simultane-
ously study two defined age cohorts of aged as well as young erythrocytes in circulation. 
We have extensively used this technique to look at erythrocyte loss in mouse models of 
anemia induced by (a) heavy metal cadmium (Cd), (b) herbicide Paraquat (PQ), (c) car-
bon nanotubes (CNTs), and (d) autoantibody in autoimmune hemolytic anemia (AIHA). 
We have found that the pattern of erythrocyte removal is distinctly different in different 
models of murine anemia. In certain types of anemia (CNT and AIHA), younger eryth-
rocytes in blood circulation are preferentially removed, whereas in other cases (Cd and 
PQ), old erythrocytes are specifically eliminated.
Keywords: DIB technique, flow cytometry, erythrocyte turnover, anemia, mouse models 
of anemia, cadmium, Paraquat, carbon nanotubes, autoantibody, AIHA
1. Introduction
Erythrocytes constitute almost 99.9% of all blood cells, excluding platelets. Erythrocytes have a 
definite lifespan in the circulation during which time they shuttle through the entire body sev-
eral times exchanging respiratory gases between tissues and organs. The lifespan of human and 
murine erythrocytes has been estimated to be around 120 and 50 days, respectively, indicating 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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that roughly 1% of all circulating erythrocytes in human and 2% in mice are destroyed each 
day [1–3]. Erythrocytes undergo repetitive cycles of oxidation and reduction during gaseous 
exchange, are regularly exposed to severe osmotic shock while passing through the kidney 
medulla, and have to squeeze through very narrow blood capillaries. As the erythrocytes age 
in circulation, these repeated insults result in accumulation of several changes in the cell, par-
ticularly in the membrane composition. These damaged erythrocytes are prone to destruction 
in the reticuloendothelial system (RES) in the spleen, bone marrow, and liver [4].
Studies in the past have aimed to decipher the actual kinetics of erythrocyte turnover in 
circulation, but their approaches have been marred by the unavailability of a suitable tech-
nique to identify erythrocytes of different age groups. Mostly they have relied upon buoyant 
density of the erythrocytes [5, 6] or hyper-transfusion studies [7]. Later with the advent of 
biotinylation studies [8–10], things became clearer, and finally with the novel double in vivo 
biotinylation (DIB) technique developed in our lab [11, 12], we have now been able to solve 
the mystery of the kinetics of erythrocyte survival in the blood [11–16]. Studies on eryth-
rocyte survival kinetics and the associated age-related changes in buoyant density, auto-
fluorescence, and phosphatidylserine (PS) externalization have extensively been reviewed 
in Saxena et al. [16].
Using the DIB technique, erythrocyte turnover kinetics in a normal murine system is now 
well understood. However in the case of anemia, where the homeostasis between erythrocyte 
destruction and erythropoiesis is disturbed, the erythrocyte turnover pattern may completely 
alter. To understand the fate of erythrocyte turnover in conditions of anemia, we studied four 
mouse models of experimental anemia, namely anemia induced by (a) toxic heavy metal cad-
mium (Cd) ions [17], (b) herbicide Paraquat (PQ) [18], (c) carbon nanotubes (CNTs) [19], and 
(d) autoantibody in autoimmune hemolytic anemia (AIHA) [20].
2. The double in vivo biotinylation (DIB) technique
Advent of the DIB technique, recently developed in our laboratory, has made it possible 
to simultaneously enumerate and study erythrocytes of different age groups in blood cir-
culation [11, 12, 16]. In the DIB protocol, circulating erythrocytes were biotinylated in two 
steps by intravenous administration of biotin-X-N-hydroxysuccinimide ester (BXN), through 
the tail vein of mice. The first step of high-intensity biotinylation involved three daily intra-
venous (i.v.) injections of biotin (1 mg), followed after few days by a low-intensity biotin 
injection with a single lower dose (0.6 mg). The first step labels all the erythrocytes pres-
ent in circulation at the time of injection, while the second step labels the fresh erythrocytes 
that were released in circulation in the period between the two biotinylation steps. At any 
time point after the second biotinylation, biotin intensity on circulating erythrocytes could be 
analyzed by flow cytometry after staining the erythrocytes with streptavidin coupled to an 
appropriate fluorochrome [11, 12, 16]. As such erythrocytes in circulation could be grouped 
into three distinct cohorts: (i) biotinnegative erythrocytes that represents the fresh erythrocytes 
that were released in the blood after the second step of biotinylation, (ii) biotinlow erythrocytes 
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that consists of the cohort of erythrocytes released in the blood between the two steps of bioti-
nylation, and (iii) biotinhigh erythrocytes that comprise the residual erythrocytes from the ones 
that were present in circulation at the time of the first biotinylation step [16]. The DIB protocol 
has been summarized in Figure 1.
Time interval between the two biotin injections can be altered according to the requirement of 
the experiment [16]. In DIB protocol A, a window of 5 days is provided between the two steps. 
This enables us to track the circulating erythrocytes from the moment of its release into the 
bloodstream till the end of its lifespan. Alternatively by introducing a long gap (of about 30 
days) in DIB protocol B, two defined cohorts of aged as well as young erythrocytes in circula-
tion can be identified and studied simultaneously. For details, see Figure 1.
Figure 1. Double in vivo biotinylation (DIB) technique. C57BL/6 mice were given three daily i.v. doses of 1 mg BXN 
(first biotinylation step), followed, after a rest for several days, by a single additional dose of 0.6 mg BXN (second 
biotinylation step). Biotin label on erythrocytes was examined at different time points by bleeding the mice and staining 
the cells with streptavidin-APC followed by flow cytometry. In DIB protocol A, a window of 5 days is provided between 
the two biotinylation steps; in DIB protocol B, a long gap of 30 days is introduced. Principle of the technique and 
the residual biotin label on circulating erythrocytes are shown above. Erythrocyte populations in boxes X, Y, and Z 
represent biotinhigh, biotinlow, and biotinnegative erythrocytes, respectively; values in parentheses represent percentage of 
cells in different boxes.
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3. Erythrocyte turnover in the blood
Erythrocytes have a definite lifespan in the circulation during which time they shuttle through 
the entire body several times exchanging respiratory gases between tissues and organs. Using 
the DIB technique, we have been able to follow the survival kinetics of a cohort of erythro-
cytes of defined age, with a degree of precision not possible so far. Based on this technique, 
Khandelwal and Saxena [11] described the triphasic nature of survival kinetics of blood eryth-
rocytes in circulation. This profile has been depicted in Figure 2. In this system, a defined cohort 
of erythrocytes remained more or less constant till 10 days after their release in circulation and 
Figure 2. Survival kinetics of erythrocytes in circulation. C57BL/6 mice were DIB labeled following protocol A. At 
different time points, the biotinlow population was assessed as percentage of all circulating erythrocytes and followed 
throughout their lifespan in the blood. Panel A shows the survival kinetics of murine erythrocytes. Correlation 
coefficients and slopes of the three phases of the decay curve have been calculated (n = 14). PS externalization and 
expression of CD47 and CD147 were studied on the biotinlow population during its lifespan in the blood. Panel B shows 
the proportion of PS+ erythrocytes. As compared to the first time point, the decline in PS expression on all subsequent 
time points was statistically significant. CD47 and CD147 expression are given in panels C and D, respectively. Mean 
CD47 and CD147 expression on the biotinlow population has been expressed as percentage of the mean expression on all 
blood erythrocytes. Each point in the graph represents mean ± SD of observations. n = 5. *p < 0.05 for comparison of the 
groups. Statistical analysis was done using Student t-test.
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started to decline constantly thereafter, indicating a random destruction irrespective of age. 
The rate of this decline increased after about 40 days in circulation, suggesting the onset of an 
age-dependent selective killing of erythrocytes [11, 15]. Thus the true picture of erythrocyte 
destruction in mice circulation appears to be a combination of both random killing, at least in 
the first segment of the life cycle, and the age-dependent destruction, especially in the latter 
part of the life span.
The factors that drive such unique survival kinetics of circulating erythrocytes are not clearly 
understood. The role of PS externalization might be critical in this respect. Annexin V staining 
of biotinlow erythrocytes at different time points reveals that PS extrusion is more efficient in 
younger erythrocytes rather than in senescent ones (Figure 2B) [12]. It is likely that younger 
erythrocytes that get damaged due to oxidative or other forms of stress may readily extrude 
PS and undergo erythrophagocytosis, leading to random killing of erythrocytes. On the other 
hand, a steady fall in CD47 [14] and CD147 [11] expression has been observed during aging of 
erythrocytes (Figure 2C and D). These may render older erythrocytes susceptible to phago-
cytosis by macrophages.
4. Murine models of anemia
4.1. Cadmium (Cd)-induced anemia
Cadmium, one of the most toxic heavy metals, a category I carcinogen [21], is a nonbiodegrad-
able environmental contaminant that can cause serious health hazard [21–24]. Exposure to 
cadmium may occur through contamination in food and drinking water [25], cigarette smoke 
[26, 27], or through occupational exposure in mining and manufacturing industries [23, 27, 28]. 
Cadmium has a long biological half-life of 10–30 years and can accumulate into various 
organs and tissues, particularly in kidneys [29] and also in the lung, liver, bone, testis, cardio-
vascular, and the immune systems, causing severe damage [29, 30]. Anemia as a consequence 
of cadmium toxicity has been observed in many cases of human exposure [31–33] and also in 
animal models [34–38].
In our experiment groups of mice were given 1000 ppm of cadmium chloride in drinking 
water, and their blood parameters were monitored every week. Continuous exposure to cad-
mium induced a significant decline in erythrocyte count and hemoglobin content, indicat-
ing anemia (Figure 3, panels A and B). A significant decline in blood parameters could be 
observed as early as in the second week of exposure [17]. Exposure to lower dose of cadmium 
(50 ppm CdCl
2
) resulted in the development of a transient anemia in mice [17].
4.2. Herbicide Paraquat (PQ)-induced anemia
Paraquat (N, N′-dimethyl-4, 4′-bipyridinium dichloride, PQ), one of the most widely used her-
bicide, kills plants rapidly by deactivating the photosynthetic mechanism. It also has consider-
able toxicity toward animals and humans and has widely been used for suicide throughout 
the world [39–41]. Ingestion of PQ causes liver, lung, heart, and kidney failure within several 
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days to several weeks [42]. A link between the exposure to PQ and Parkinson’s disease has also 
been reported [43]. PQ is a potent inducer of reactive oxygen species (ROS), and occurrence of 
anemia as a consequence of exposure to PQ has also been documented [44, 45]. The use of PQ 
was banned in Europe in 2007, but the herbicide is still widely used in the rest of the world.
Figure 3. Induction of anemia in mice. Anemia was induced in mice through different stimuli. Blood samples from mice 
were collected at different time points and analyzed on an automated cell counter. Erythrocyte count and hemoglobin 
content in cadmium (Cd)-induced anemia (panels A and B), Paraquat (PQ)-induced anemia (panels C and D), carbon 
nanotube (CNT)-induced anemia (panels E and F), and autoimmune hemolytic anemia (AIHA, panels G and H) are 
shown above. Each point on the graph represents mean ±SEM of observations. n = 10. *p < 0.05, **p < 0.01, and ****p < 0.001 
for comparison of the groups. Statistical analysis was done using Student t-test.
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In our experiment mice were administered repeated doses of Paraquat (Paraquat dichloride 
hydrate freshly dissolved in phosphate buffered saline (PBS), 10 mg/kg of body weight) intra-
peritoneally (i.p.) on alternate days [18, 43]. Control mice received vehicle alone. Blood param-
eters were monitored at different time points. Paraquat treatment induced a transient anemia 
in mice, indicated by a significant decline in blood erythrocyte count (up to 45%) as well as 
blood hemoglobin levels (upto 38%) on 7, 14, and 21 day time points (Figure 3, panels C and D) 
[18]. Erythrocyte count as well as blood hemoglobin levels however returned to normal by the 
end of 4 weeks, even though PQ treatment was continued.
4.3. Carbon nanotube (CNT)-induced anemia
Nanoparticles are defined as particulate dispersions or solid particles with a size in the range 
of 10–100 nm. Single-walled carbon nanotubes (SWCNTs) are a class of engineered nano-
materials that represent rolled-up tubes of graphite sheet of sp2 hybridized carbon atoms, 
having a diameter of about 1 nm. Due to their unique structural and remarkable electronic, 
mechanical, and chemical properties, engineered nanomaterials find wide applications in 
molecular electronics, microdevices, gas storage, catalytic supports, aerospace, automobile, 
and atomic force microscopy and biological applications like biosensors, drug delivery, etc. 
[46–48]. Interaction of nanoparticles with the body is dependent on their size, chemical com-
position, surface structure, solubility, and shape [49–51]. Several studies have demonstrated 
the toxicity of SWCNT to different types of cells in vitro [52–54] and in vivo [55–58].
In our experiment, mice were administrated i.v. 10 mg acid-functionalized SWCNTs 
(AF-SWCNTs) on alternate days, and blood parameters were examined at different time points. 
Significant decline in erythrocyte count as well as hemoglobin levels was observed at different 
time points during the treatment with AF-SWCNTs [19]. Results in Figure 3, panels E and F 
show that erythrocyte count and hemoglobin levels decreased by 10–22% and 13–25%, respec-
tively, at different time points. Repeated administration of AF-SWCNTs (10 mg) induced a 
sustained anemia in mice [19].
4.4. Autoimmune hemolytic anemia (AIHA)
Autoimmune hemolytic anemia (AIHA) is characterized by the production of pathogenic self-
reactive autoantibodies against self-erythrocytes that can result in premature destruction of 
erythrocytes leading to the clinical manifestation of anemia [59–62]. Pathogenesis of AIHA 
involves two underlying mechanisms, namely erythrophagocytosis of autoantibody-coated 
erythrocytes by macrophages in the reticuloendothelial system in the liver and spleen [63, 64] 
and complement-mediated lysis of erythrocytes following binding of IgM autoantibodies [65].
AIHA could be induced in mice following the Playfair and Clarke Model [66], based on 
Weigle’s hypothesis of termination of immunological unresponsiveness to an antigen by injec-
tion of a cross-reacting antigen with similar/shared epitopes [67]. In this model repeated injec-
tion of rat erythrocytes induces production of autoantibodies against self-erythrocytes in mice 
[68–70]. The immunized mice develop autoimmune anemia, a severe but transient one, charac-
terized by the presence of both anti-mouse autoantibody and the usual anti-rat antibody [69].
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In our experiment mice were given weekly i.p. injections of 2 × 108 rat erythrocytes, and blood 
parameters were monitored at regular intervals. Generation of anti-mouse erythrocyte auto-
antibody was estimated by flow cytometric analysis of erythrocytes stained with anti-mouse 
IgG/IgM-fluorescein isothiocyanate (FITC) polyclonal antibodies [71, 72]. The results show 
that a significant anemia was demonstrable in the immunized mice only after 5–6 weekly 
administrations of rat erythrocytes [20], when the blood erythrocyte count suffered a 10% 
decline and hemoglobin a staggering 15% decline (Figure 3, panels G and H, respectively). 
The anti-mouse erythrocyte autoantibody level also showed a sharp increase at the same time 
point [20], indicating an autoimmune response.
5. Erythrocyte turnover pattern in different models of anemia
Turnover profile for the various age cohorts of circulating erythrocytes was examined by 
utilizing the DIB technique of erythrocyte labeling in vivo to analyze the age-dependent sus-
ceptibility of circulating erythrocytes to the different mediators of stress, Cd, PQ, CNTs, and 
AIHA. Erythrocytes isolated from the peripheral blood of the DIB-labeled mice were stained 
ex vivo with streptavidin-allophycocyanin (APC) and anti-mouse CD71-PE followed by flow 
cytometry. Circulating erythrocytes were delineated as per the relative streptavidin and 
CD71 staining into four different groups: biotinhigh (older erythrocytes), biotinlow (intermedi-
ate age group), CD71−biotinnegative (young) erythrocytes, and CD71+biotinnegative reticulocytes. 
A representative flow diagram is shown in Figure 4. A comparison of the proportion of erythrocytes 
Figure 4. Age cohorts of circulating erythrocytes. Mouse erythrocytes were labeled with biotin in vivo by the two-
step biotinylation procedure (DIB protocol B). Blood samples were collected, and erythrocytes were stained ex vivo 
with streptavidin-APC and anti-mouse CD71-PE. Proportions of the different age cohorts were determined as biotinhigh 
(older erythrocytes), biotinlow (intermediate age group), CD71−biotinnegative (young erythrocytes), and CD71+biotinnegative 
reticulocytes. Representative flow histograms showing the proportion of different age groups of erythrocytes are shown.
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belonging to different age cohorts would give their turnover profile. Interestingly, results 
from the four models of murine anemia could be clustered into two distinct categories, with 
completely contrasting characters.
5.1. Increased susceptibility of older erythrocytes: Cd and PQ
Exposure to environmental toxicants cadmium and Paraquat resulted in a very similar response 
in terms of erythrocyte turnover. The turnover profiles indicate that the kinetics of decline of 
older erythrocytes (biotinhigh subpopulations that entered blood circulation before the first bio-
tinylation step; Figure 5, panels A and B) and the increase in the proportion of younger sub-
population of erythrocytes (biotinnegative, entering blood circulation after the second biotinylation 
step; Figure 5, panels C and D) was significantly higher in the treatment groups than the con-
trol (Figure 5) [17, 18]. These results suggest that the older erythrocytes in blood circulation 
may be preferentially eliminated in the toxicant (Cd or PQ)-exposed mice, leaving the young 
Figure 5. Erythrocyte turnover in the blood of mice exposed to cadmium and Paraquat. Mice were rendered anemic 
by exposure to toxicants like cadmium and Paraquat. Mouse erythrocytes were labeled with biotin in vivo by the two-
step biotinylation procedure (protocol A). Erythrocytes were stained ex vivo with streptavidin-APC, and proportions 
of the different age cohorts were determined. Turnover profile of relatively aged biotinhigh (panels A and B) and young 
biotinnegative (panels C and D) erythrocytes in cadmium-treated (panels A and C) and Paraquat-treated (panels B and D) 
mice has been shown above. Each point on the graph represents mean ±SEM of observations. n = 10. *p < 0.05 and **p < 0.01 
for comparison of the groups. Statistical analysis was done using Student t-test.
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 erythrocytes to accumulate in circulation, indicated by the significant increase in the proportion 
of the younger biotinnegative erythrocytes. This could indicate either an increased generation of 
fresh erythrocytes or prolonged life span of younger erythrocytes in blood circulation.
The latter view is again supported by the enhanced reticulocytosis in both cadmium-induced 
and Paraquat-induced anemia (Figure 6). An initial surge of reticulocytes in mice exposed to 
cadmium and Paraquat was clearly seen. This surge was however lost by the fourth and fifth 
weeks of cadmium (Figure 6A) [17] and Paraquat (Figure 6B) [18] exposure, respectively.
5.2. Increased susceptibility of young erythrocytes: CNTs and AIHA
Autoimmune hemolytic anemia (AIHA) and anemia induced by exposure to AF-SWCNTs are 
characterized by a unique turnover profile of circulating erythrocytes, which is radically dif-
ferent from the one observed in Cd- and PQ-induced anemia. There is a significant increase 
(twofold) in the proportion of older erythrocyte population (biotinhigh, Figure 7, panels A and C) 
along with a concomitant decline in the proportion of young erythrocytes (Figure 7, panels B 
and D). Thus relatively younger erythrocytes in the blood seem to be preferentially eliminated in 
conditions of AIHA- [20] and CNT-induced anemia [19] either by macrophage-mediated eryth-
rophagocytosis in the reticuloendothelial system of the spleen or by complement-mediated lysis.
In the turnover profile though comparable in both AIHA- and CNT-induced anemia, the two 
models revealed very different results in terms of the reticulocyte response. The AF-SWCNT 
treatment resulted in reticulocytosis, showing > twofold increase in the percentage of blood 
reticulocytes from 2.23 to 5.32% (Figure 8A) [19]. Autoimmune anemia on the other hand 
resulted in severe reticulocytopenia, showing a 16–18% decline in reticulocyte proportion as 
seen in Figure 8, panel B [20].
Figure 6. Circulating reticulocytes in cadmium- and Paraquat-induced anemia. Mice were rendered anemic by 
exposure to toxicants like cadmium chloride and Paraquat. Blood was collected at regular interval, and mouse 
erythrocytes were stained ex vivo with anti-mouse CD71-PE to determine the proportion of circulating reticulocytes 
through flow cytometry. Panel A shows the relative proportions of reticulocytes in cadmium-fed mice. For this, the mean 
reticulocyte counts in control mice at each time point was taken as 100, and the proportion of reticulocytes in the exposed 
groups was estimated in relative terms. Panel B shows the reticulocyte proportion in the Paraquat-treated mice. Each 
point on the graph represents mean ±SEM of observations. n = 10. *p < 0.05, **p < 0.01, and ***p < 0.005 for comparison of 
the groups. Statistical analysis was done using Student t-test.
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Figure 7. Erythrocyte turnover in the blood of AIHA mice and mice exposed to AF-SWCNTs. Mice were rendered anemic by 
injecting AF-SWCNTs or by inducing AIHA. Mouse erythrocytes were labeled with biotin in vivo by the two-step biotinylation 
procedure (protocol A for CNT-induced anemia; protocol B for AIHA). Erythrocytes were stained ex vivo with streptavidin-
APC, and proportions of the different age cohorts were determined. Turnover profile of relatively aged biotinhigh (panels A and 
C) and young biotinnegative (panels B and D) erythrocytes in AF-SWCNT-treated mice (panels A and B) and AIHA mice (panels C 
and D) has been shown above. The time point for AIHA has been selected on the basis of the induction of anemia (only after the 
fifth and sixth immunization doses). Each point and each bar on the graph represent mean ±SEM of observations. n = 10. *p < 0.05, 
**p < 0.01, and ***p < 0.005 for comparison of the groups. Statistical analysis was done using Student t-test.
Figure 8. Circulating reticulocytes in the blood of AIHA mice and mice exposed to AF-SWCNTs. Mice were rendered 
anemic by injecting AF-SWCNTs or by inducing AIHA. Blood was collected at regular interval, and mouse erythrocytes 
were stained ex vivo with anti-mouse CD71-PE to determine the proportion of circulating reticulocytes through flow 
cytometry. Panel A shows the relative proportions of reticulocytes in AF-SWCNT-treated mice. For this, the mean 
reticulocyte counts in control mice at each time point was taken as 100, and the proportion of reticulocytes in the exposed 
groups was estimated in relative terms. Panel B shows the reticulocyte proportion in the AIHA mice. The time point for 
AIHA has been selected on the basis of the induction of anemia (only after the fifth and sixth immunization doses). Each 
point and each bar on the graph represent mean ±SEM of observations. n = 10. *p < 0.05, **p < 0.01, and ***p < 0.005 for 
comparison of the groups. Statistical analysis was done using Student t-test.
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6. Conclusion
The technique of double in vivo biotinylation has been used extensively in our laboratory to 
unravel the changes associated with erythrocyte aging in circulation. In the present study, 
the same DIB technique has been used to track the stress-related changes in different age 
cohorts of erythrocytes and ascertain their susceptibility in different types of anemia. To 
achieve this goal, we have compared the erythrocyte turnover patterns in four different mod-
els of murine anemia, namely anemia induced by (a) toxic heavy metal cadmium (Cd) ions, 
(b) herbicide Paraquat (PQ), (c) carbon nanotubes (CNTs), and (d) autoantibody in autoim-
mune hemolytic anemia (AIHA). Interestingly, the study revealed two distinct and contrast-
ing patterns of erythrocyte turnover in murine anemia. This difference could be because of 
the difference in the way the stress inducers interact with the cell in each of the models. In 
certain types of anemia, where erythrocytes are exposed to toxicants that directly enter the 
cells, like in the case of cadmium [73] and Paraquat [74, 75], the stress inducers might inter-
fere with enzyme activities and signaling processes, thereby promoting senescent changes 
within the cell. Therefore in toxicant stress, as in cadmium-induced anemia and Paraquat-
induced anemia, older erythrocytes that are already undergoing senescent changes become 
more susceptible and are preferentially removed from circulation [17, 18]. On the other hand, 
in some other cases, where erythrocytes are exposed to agents that directly interact with 
the cell membrane, as in the case of AIHA- [70, 76] and AF-SWCNT-induced anemia [57], 
younger erythrocytes in blood circulation are preferentially removed [19, 20]. This biasness 
could be due to the difference in the membrane composition in the different age cohorts of 
erythrocytes [77–79]. The fate of the erythrocytes in anemic mice therefore depends on the 
characteristics and behavior of the stress mediator and therefore may be different in different 
types of anemia.
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Appendices and nomenclatures
AF-SWCNT Acid-functionalized single-walled carbon nanotube
AIHA Autoimmune hemolytic anemia
ANOVA Analysis of variance
APC Allophycocyanin
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BXN Biotin-X-N-hydroxysuccinimide ester
CD Cluster of differentiation
Cd Cadmium
CdCl
2
Cadmium chloride
CNT Carbon nanotubes
DIB Double in vivo biotinylation
FITC Fluorescein isothiocyanate
Ig Immunoglobulin
i.p. Intraperitoneal
i.v. Intravenous
NHS N-hydroxysuccinimide
PBS Phosphate-buffered saline
PE Phycoerythrin
ppm Parts per million
PQ Paraquat
PS Phosphatidylserine
RES Reticuloendothelial system
ROS Reactive oxygen species
SEM Standard error of the mean
SWCNT Single-walled carbon nanotube
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